WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2022)
Top pharmaceutical stocks in 2022 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

Industry: Drug Manufacturers - Spec...
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Consensus
Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
RDY
DR REDDYS LABORATORIES LTD
$9.37B$56.29$67.0019.03%Strong Buy18.84%22.05%22.33%14.53%
IRWD
IRONWOOD PHARMACEUTICALS INC
$1.88B$12.26$14.5018.27%Buy25.61%12.10%39.71%22.56%
VTRS
VIATRIS INC
$13.55B$11.17$12.8815.26%Hold9-1.81%70.21%20.99%8.27%
PAHC
PHIBRO ANIMAL HEALTH CORP
$503.86M$12.44$18.5048.71%Sell2-0.60%11.81%24.66%6.83%
PCRX
PACIRA BIOSCIENCES INC
$2.17B$47.25$75.0058.73%Buy612.78%128.94%30.09%13.36%
ACRX
ACELRX PHARMACEUTICALS INC
$16.69M$2.24N/AN/AHold1107.10%N/A-5.47%-3.08%
AMPH
AMPHASTAR PHARMACEUTICALS INC
$1.46B$30.21$38.0025.79%Strong Buy45.76%3.93%17.51%12.17%
PRPH
PROPHASE LABS INC
$167.17M$10.27$15.0046.06%Buy1-27.43%-27.54%21.81%15.13%
ASRT
ASSERTIO HOLDINGS INC
$147.78M$3.06$6.50112.42%Strong Buy2-15.35%-47.76%N/AN/A
ORGO
ORGANOGENESIS HOLDINGS INC
$356.09M$2.72N/AN/AHold12.23%-53.19%13.79%7.73%
SLDB
SOLID BIOSCIENCES INC
$51.01M$6.77$7.003.40%Buy571.94%N/A-4.52%-3.51%
EOLS
EVOLUS INC
$412.29M$7.33$13.0077.35%Buy326.13%N/A159.77%24.22%
CRON
CRONOS GROUP INC
$1.31B$3.46$3.40-1.79%Hold532.42%N/A0.32%0.31%
CALT
CALLIDITAS THERAPEUTICS AB
$531.96M$18.00$62.00244.44%Buy1143.69%N/A777.62%384.52%
ZTS
ZOETIS INC
$73.37B$157.42$219.1739.22%Strong Buy66.22%13.00%68.27%23.28%
OGI
ORGANIGRAM HOLDINGS INC
$373.44M$1.19$2.0874.62%Buy832.34%N/A4.93%4.34%
BHC
BAUSCH HEALTH COMPANIES INC
$2.87B$7.93$7.33-7.53%Hold53.05%91.04%-400.47%7.99%
DRRX
DURECT CORP
$90.92M$0.40$5.331,236.59%Strong Buy361.53%N/A542.62%276.21%
DERM
JOURNEY MEDICAL CORP
$32.75M$1.85$12.67584.70%Strong Buy38.53%N/A218.40%52.88%
GHSI
GUARDION HEALTH SCIENCES INC
$10.41M$0.17$0.68299.41%Strong Buy2N/AN/AN/AN/A
SNDL
SNDL INC
$741.29M$3.13$2.15-31.31%Hold3-42.18%N/A0.23%0.18%
AGRX
AGILE THERAPEUTICS INC
$8.24M$0.20$3.001,377.83%Buy375.77%N/A58.39%19.80%
CTLT
CATALENT INC
$9.40B$52.25$82.2957.49%Buy89.77%31.88%21.40%9.86%
AMYT
AMRYT PHARMA PLC
$457.40M$7.15$18.67161.08%Strong Buy327.92%-1.72%37.48%16.49%
SBFM
SUNSHINE BIOPHARMA INC
$17.84M$0.79N/AN/AN/AN/AN/AN/AN/AN/A
TARO
TARO PHARMACEUTICAL INDUSTRIES LTD
$1.14B$30.46$54.0077.28%Buy1N/AN/AN/AN/A
CGC
CANOPY GROWTH CORP
$2.08B$4.29$4.556.06%Strong Sell620.43%N/A-11.47%-5.48%
EVOK
EVOKE PHARMA INC
$5.55M$1.66$10.00502.41%Strong Buy1N/AN/AN/AN/A
OPTN
OPTINOSE INC
$146.16M$1.75$5.00185.71%Strong Buy231.03%N/A-39.82%27.77%
THTX
THERATECHNOLOGIES INC
$128.44M$1.35$9.00566.67%Strong Buy125.07%N/A-167.21%31.50%
EBS
EMERGENT BIOSOLUTIONS INC
$598.66M$12.00$40.67238.89%Buy4-11.01%29.73%6.57%3.28%
EGRX
EAGLE PHARMACEUTICALS INC
$467.40M$35.91$43.0019.74%Buy3-12.52%N/AN/AN/A
ZYNE
ZYNERBA PHARMACEUTICALS INC
$28.05M$0.60$11.001,745.64%Strong Buy1N/AN/A66.01%55.84%
ACB
AURORA CANNABIS INC
$420.61M$1.40$3.00114.29%Hold125.28%N/A-0.74%-0.35%
CLVR
CLEVER LEAVES HOLDINGS INC
$22.95M$0.52$2.85448.08%Buy3N/AN/AN/AN/A
PLXP
PLX PHARMA INC
$9.73M$0.33$10.002,894.01%Hold3116.01%N/A-80.09%-24.56%
SCTL
SOCIETAL CDMO INC
$96.39M$1.70$3.0780.29%Strong Buy27.96%N/A0.00%0.00%
SCYX
SCYNEXIS INC
$75.11M$2.30$8.00247.83%Strong Buy2128.52%N/A-108.17%-16.58%
HEXO
HEXO CORP
$111.78M$0.19$0.3061.29%Hold212.57%N/A2.64%1.22%
INCR
INTERCURE LTD
$220.70M$4.89$11.50135.17%Strong Buy2N/AN/AN/AN/A
PRGO
PERRIGO CO PLC
$4.30B$31.94$47.3348.19%Strong Buy33.91%N/A11.20%4.83%
NLTX
NEOLEUKIN THERAPEUTICS INC
$19.81M$0.47$5.981,186.02%Hold7N/AN/A-111.68%-93.21%
RLMD
RELMADA THERAPEUTICS INC
$138.46M$4.60$25.00443.48%Hold4N/AN/A-26.24%-23.32%
TLRY
TILRAY BRANDS INC
$2.46B$4.58$3.91-14.54%Hold712.11%N/A0.85%0.69%
ZOM
ZOMEDICA CORP
$199.91M$0.20N/AN/AN/AN/AN/AN/AN/AN/A
RMTI
ROCKWELL MEDICAL INC
$13.54M$1.16$8.00587.29%Buy1N/AN/A-163.65%-48.73%
TXMD
THERAPEUTICSMD INC
$42.13M$4.45$5.5023.60%Hold225.76%N/A-3.33%1.20%
BFRI
BIOFRONTERA INC
$28.03M$1.05$11.00947.62%Strong Buy151.05%N/AN/AN/A
IXHL
INCANNEX HEALTHCARE LTD
$16.54M$4.05N/AN/AN/AN/AN/AN/AN/AN/A
PRFX
PAINREFORM LTD
$4.68M$0.44$3.00581.82%Strong Buy1N/AN/AN/AN/A
RDHL
REDHILL BIOPHARMA LTD
$15.12M$0.27$15.705,802.26%Strong Buy568.97%N/A-4,938.91%1,446.15%
QLI
QILIAN INTERNATIONAL HOLDING GROUP LTD
$42.54M$1.19N/AN/AN/AN/AN/AN/AN/AN/A
VERU
VERU INC
$440.81M$5.50$35.75550.00%Strong Buy4106.33%N/A135.10%98.33%
SISI
SHINECO INC
$12.23M$0.75N/AN/AN/AN/AN/AN/AN/AN/A
HUGE
FSD PHARMA INC
$33.46M$0.88$10.001,038.95%Strong Buy1N/AN/A278.83%231.24%
CRDL
CARDIOL THERAPEUTICS INC
$33.24M$0.52$8.001,429.64%Strong Buy1N/AN/A60.85%52.23%
TKNO
ALPHA TEKNOVA INC
$138.96M$4.94$15.00203.64%Strong Buy114.35%N/AN/AN/A
NEPT
NEPTUNE WELLNESS SOLUTIONS INC
$5.58M$0.70N/AN/AHold113.28%N/A-43.02%-19.04%
KMDA
KAMADA LTD
$210.11M$4.69$11.00134.54%Strong Buy110.26%N/A10.13%5.47%
MDVL
MEDAVAIL HOLDINGS INC
$33.62M$0.42$4.50971.43%Strong Buy1N/AN/A-150.86%-94.74%
ANIP
ANI PHARMACEUTICALS INC
$678.15M$38.83$49.0026.19%Buy212.67%N/A28.96%12.22%
ADMP
ADAMIS PHARMACEUTICALS CORP
$30.00M$0.20N/AN/AHold2177.85%N/A474.39%111.22%
CPIX
CUMBERLAND PHARMACEUTICALS INC
$32.54M$2.25$8.50277.78%Strong Buy1N/AN/AN/AN/A
COLL
COLLEGIUM PHARMACEUTICAL INC
$772.83M$23.02$38.0065.07%Buy320.21%N/A35.50%5.83%
VLNS
VALENS COMPANY INC
$81.92M$1.02$3.46239.22%Buy438.47%N/AN/AN/A
EVO
EVOTEC SE
$3.23B$9.14$16.0075.05%Strong Sell113.27%N/A5.85%3.17%
HAPP
HAPPINESS DEVELOPMENT GROUP LTD
$195.38M$2.47$3.0021.46%Strong Buy12.40%N/AN/AN/A
SUPN
SUPERNUS PHARMACEUTICALS INC
$2.03B$37.51$38.001.31%Strong Buy10.55%46.01%18.19%9.16%
PETQ
PETIQ INC
$346.62M$11.86$16.0034.91%Buy16.67%N/AN/AN/A
ATNX
ATHENEX INC
$31.32M$0.20$3.001,407.54%Hold13.83%N/A-25.34%-2.76%
SXTC
CHINA SXT PHARMACEUTICALS INC
$1.52M$0.75N/AN/AN/AN/AN/AN/AN/AN/A
HROW
HARROW HEALTH INC
$339.38M$12.38$18.5049.43%Strong Buy217.92%N/A1,554.27%19.11%
FLGC
FLORA GROWTH CORP
$34.05M$0.44$1.43223.86%Buy2N/AN/A-45.71%-33.86%
PROC
PROCAPS GROUP SA
$728.84M$6.46$13.00101.24%Strong Buy1N/AN/AN/AN/A
CYTH
CYCLO THERAPEUTICS INC
$16.45M$1.94$10.00415.46%Strong Buy1N/AN/AN/AN/A
XXII
22ND CENTURY GROUP INC
$251.90M$1.17$5.00327.35%Strong Buy3N/AN/AN/AN/A
PTPI
PETROS PHARMACEUTICALS INC
$8.49M$4.10N/AN/AN/AN/AN/AN/AN/AN/A
JUPW
JUPITER WELLNESS INC
$24.73M$1.13N/AN/AN/AN/AN/AN/AN/AN/A
SNOA
SONOMA PHARMACEUTICALS INC
$5.49M$1.77N/AN/AN/AN/AN/AN/AN/AN/A
YCBD
CBDMD INC
$19.62M$0.32N/AN/AN/AN/AN/AN/AN/AN/A
ALIM
ALIMERA SCIENCES INC
$25.09M$3.58$6.7588.55%Buy29.42%N/AN/A-9.20%
UPXI
UPEXI INC
$77.59M$4.32N/AN/AN/AN/AN/AN/AN/AN/A
TAK
TAKEDA PHARMACEUTICAL CO LTD
$49.38B$14.82$24.0061.94%Buy1-6.66%N/AN/AN/A
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
$380.89M$29.27N/AN/AN/AN/AN/AN/AN/AN/A
TCDA
TRICIDA INC
$14.27M$0.25$25.0010,062.60%Hold4N/AN/AN/A-58.10%
AVDL
AVADEL PHARMACEUTICALS PLC
$573.31M$9.28$11.2521.23%Strong Buy4N/AN/A-481.72%41.11%
LCI
LANNETT CO INC
$26.66M$0.62$2.25262.90%Hold23.93%N/AN/A-8.65%
BGXX
BRIGHT GREEN CORP
$99.74M$0.59N/AN/AN/AN/AN/AN/AN/AN/A
CPHI
CHINA PHARMA HOLDINGS INC
$5.84M$0.11N/AN/AN/AN/AN/AN/AN/AN/A
AKAN
AKANDA CORP
$6.68M$0.23N/AN/AN/AN/AN/AN/AN/AN/A
COSM
COSMOS HOLDINGS INC
$44.83M$0.54N/AN/AN/AN/AN/AN/AN/AN/A
ELAN
ELANCO ANIMAL HEALTH INC
$6.26B$13.20$18.4339.61%Hold71.40%N/A11.60%5.23%
AMRX
AMNEAL PHARMACEUTICALS INC
$737.73M$2.43$4.0064.61%Strong Buy13.93%N/AN/AN/A
EMBC
EMBECTA CORP
$1.95B$33.76$29.00-14.10%Hold3N/AN/A-17.95%14.49%
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
$9.62B$8.66$10.3819.80%Hold91.14%N/A34.71%6.88%
MNK
MALLINCKRODT PLC
$138.29M$10.50N/AN/AN/AN/AN/AN/AN/AN/A
ALVO
ALVOTECH
$1.42B$6.36$10.0057.23%Hold3N/AN/A-117.01%47.49%

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Dec 2022?

According to Zen Score, the 3 best pharma stocks to buy right now are:

1. Dr Reddys Laboratories (NYSE:RDY)


Dr Reddys Laboratories (NYSE:RDY) is the top pharmaceutical stock with a Zen Score of 57, which is 28 points higher than the pharmaceutical industry average of 29. It passed 22 out of 38 due diligence checks and has strong fundamentals. Dr Reddys Laboratories has seen its stock lose -9.79% over the past year, overperforming other pharmaceutical stocks by 29 percentage points.

Dr Reddys Laboratories has an average 1 year price target of $67.00, an upside of 19.03% from Dr Reddys Laboratories's current stock price of $56.29.

Dr Reddys Laboratories stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Dr Reddys Laboratories, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second best pharmaceutical stock with a Zen Score of 57, which is 28 points higher than the pharmaceutical industry average of 29. It passed 18 out of 33 due diligence checks and has strong fundamentals. Ironwood Pharmaceuticals has seen its stock return 10.35% over the past year, overperforming other pharmaceutical stocks by 49 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $14.50, an upside of 18.27% from Ironwood Pharmaceuticals's current stock price of $12.26.

Ironwood Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Ironwood Pharmaceuticals, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) is the third best pharmaceutical stock with a Zen Score of 55, which is 26 points higher than the pharmaceutical industry average of 29. It passed 19 out of 38 due diligence checks and has strong fundamentals. Viatris has seen its stock lose -8.44% over the past year, overperforming other pharmaceutical stocks by 30 percentage points.

Viatris has an average 1 year price target of $12.88, an upside of 15.26% from Viatris's current stock price of $11.17.

Viatris stock has a consensus Hold recommendation according to Wall Street analysts. Of the 9 analysts covering Viatris, 11.11% have issued a Strong Buy rating, 11.11% have issued a Buy, 77.78% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 7 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) has an annual dividend yield of 3.86%, which is 2 percentage points higher than the pharmaceutical industry average of 2.27%. Phibro Animal Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Phibro Animal Health's dividend has shown consistent growth over the last 10 years.

Phibro Animal Health's dividend payout ratio of 41.7% indicates that its dividend yield is sustainable for the long-term.

2. Perrigo Co (NYSE:PRGO)


Perrigo Co (NYSE:PRGO) has an annual dividend yield of 3.26%, which is 1 percentage points higher than the pharmaceutical industry average of 2.27%. Perrigo Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Perrigo Co's dividend has shown consistent growth over the last 10 years.

Perrigo Co's dividend payout ratio of -127.5% indicates that its dividend yield might not be sustainable for the long-term.

3. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) has an annual dividend yield of 3.22%, which is 1 percentage points higher than the pharmaceutical industry average of 2.27%. Viatris's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Viatris's dividend has shown consistent growth over the last 10 years.

Viatris's dividend payout ratio of 71.2% indicates that its dividend yield is sustainable for the long-term.

Why are pharmaceutical stocks up?

Pharmaceutical stocks were up 0.46% in the last day, and up 3.04% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are up.

What are the most undervalued pharmaceutical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Viatris has a valuation score of 86, which is 55 points higher than the pharmaceutical industry average of 31. It passed 6 out of 7 valuation due diligence checks.

Viatris's stock has dropped -8.44% in the past year. It has overperformed other stocks in the pharmaceutical industry by 30 percentage points.

2. Acelrx Pharmaceuticals (NASDAQ:ACRX)


Acelrx Pharmaceuticals (NASDAQ:ACRX) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Acelrx Pharmaceuticals has a valuation score of 71, which is 40 points higher than the pharmaceutical industry average of 31. It passed 5 out of 7 valuation due diligence checks.

Acelrx Pharmaceuticals's stock has dropped -81.72% in the past year. It has underperformed other stocks in the pharmaceutical industry by -43 percentage points.

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Ironwood Pharmaceuticals has a valuation score of 71, which is 40 points higher than the pharmaceutical industry average of 31. It passed 5 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 10.35% in the past year. It has overperformed other stocks in the pharmaceutical industry by 49 percentage points.

Are pharmaceutical stocks a good buy now?

42.5% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 72.17% over the next year.

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is 19.65x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.